3-D Matrix, EBIT

As of the most recent data (July 2026), DMTRF shows a EBIT of $2.6B. That compares with $-1.4B in the prior-year period — up 287.0% year over year. That is below the Healthcare sector average of $130B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DMTRF's EBIT is now $2.6B (was $-1.4B) — a 287.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether 3-D Matrix, is outperforming or lagging.

The Healthcare sector average EBIT is about $130B. 3-D Matrix, is at $2.6B, which is lower that average. That is roughly 98.1% below the sector mean. Use the comparison chart on this page to see how DMTRF stacks up against individual peers as well.

Tracking DMTRF's ebit over time shows whether 3-D Matrix, is scaling, shrinking, or reshaping that part of the business. The current reading is $2.6B That compares with $-1.4B in the prior-year period — up 287.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has 3-D Matrix,'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $2.6B) with ownership activity and broader fundamentals.